GE Healthcare launches Lullaby Incubator TR and Lullaby Incubator XP for treatment of neonates at Arab Health

Notes and media contacts

High levels of bilirubin can occur in the blood called hyperbilirubinemia. These high levels can be dangerous to a baby. It is important to obtain periodic blood samples to check the bilirubin levels and, if necessary, to treat jaundice to ensure the healthy development of your child. Phototherapy with or without a Billiblanket is the most common form of treatment for neonatal jaundice. This treatment is used for a few days until the liver is mature enough to handle the bilirubin on its own. Some "normal" jaundice will disappear within a week or two without treatment. Other babies will require treatment because of the severity of the jaundice, the cause of the jaundice, or how old the baby is when jaundice appears.

Phototherapy (light treatment) is the process of using light to eliminate bilirubin in the blood. A baby's skin and blood absorb these light waves. These light waves are absorbed by the baby's skin and blood and change bilirubin into products, which can pass through their system. For over 30 years, phototherapy treatment in the hospital has been provided by a row of lights or a spotlight suspended at a distance form a baby. This would provide light shining directly on an undressed baby (with diaper on) whose eyes would need protection from the light with soft eye patches applied. Today, advancements in technology have led to a new phototherapy system, which gives effective treatment without the inconveniences of conventional phototherapy treatment. Billiblanket phototherapy is a developmental care product. This gives high intensity cold phototherapy for the treatment of jaundice without the need of eye to be covered, baby to be naked, day night cycle affected, reducing insensible waterloss and overall reducing stress to the baby during phototherapy.

About GE Healthcare:

GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17bn unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries.

For further information, please contact:

Kelly Home / Roisin Lillis
ASDA'A Burson-Marsteller
Tel: (+971 4) 334 4550